Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes.

Core Evid · 2005 · PMC3321660 · PMID 22500147

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients who switched from inhaled insulin to subcutaneous insulin showed a trend towards worsening satisfaction scores.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.